跳轉至內容
Merck

1.37036

SAFC

二水合磷酸氢二钠

EMPROVE® EXPERT, Ph. Eur., BP, USP

製藥生產

同義詞:

磷酸钠 二元 二水合物, sec-磷酸钠, 磷酸二钠, 磷酸氢二钠 二水合物

登入查看組織和合約定價


About This Item

線性公式:
Na2HPO4 · 2H2O
CAS號碼:
分子量::
177.99
MDL號碼:
分類程式碼代碼:
12352302
酶委員會索引編號:
231-448-7
暫時無法取得訂價和供貨情況

agency

BP
Ph. Eur.
USP

品質等級

描述

EMPROVE® EXPERT Ph Eur,BP,USP

產品線

EMPROVE® EXPERT

形狀

solid

特點

RNase and DNase free

pH值

8.9-9.2 (5% in H2O)

mp

92.5 °C (Elimination of water of crystallisation)

溶解度

93 g/L

密度

2.1 g/cm3 at 20 °C

應用

liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical

儲存溫度

15-25°C

SMILES 字串

O.O.[Na+].[Na+].OP([O-])([O-])=O

InChI

1S/2Na.H3O4P.2H2O/c;;1-5(2,3)4;;/h;;(H3,1,2,3,4);2*1H2/q2*+1;;;/p-2

InChI 密鑰

KDQPSPMLNJTZAL-UHFFFAOYSA-L

尋找類似的產品? 前往 產品比較指南

一般說明

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

di-Sodium hydrogen phosphate dihydrate is typically used as a phosphate buffer system component for biomolecule downstream chromatography steps or final liquid formulation.
Due to its low microbial and endotoxin limits, di-Sodium hydrogen phosphate dihydrate Emprove® Expert is especially suitable for high-risk applications.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


什麼是Emprove® 套裝?

Emprove® 計劃是一個為我們的篩選器和單次用元件、製藥原料和起始材料提供全面徹底記錄的系統。

Material Qualification Dossier

免費—登入下載

Operational Excellence Dossier

可透過訂閱或付費取得

了解更多效益 Emprove® 計畫訂閱可提供
為什麼沒有這些文件?
Emprove® 檔案包含旨在支持藥品生產商的註冊過程和風險評估活動的訊息,並包含機密資訊。如果您想存取,請聯絡我們

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

相關內容

ADC 生產中的結合步驟是透過穩定的連結劑,將高效活性藥物成分 (HPAPI) 連接到 mAb。有效的結合過程涉及複雜的決策,本頁將概述可確保成功的服務與產品。

The conjugation step in ADC production attaches a highly potent active pharmaceutical ingredient (HPAPI) to a mAb via a stable linker. Effective conjugation involves complex decisions, outlined on this page with services and products to assure success.

Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務